Click Here!Click Here!
Home / Health / FDA Rejects Oral Testosterone-Replacement Drug Rextoro
FDA Rejects Oral Testosterone-Replacement Drug Rextoro

FDA Rejects Oral Testosterone-Replacement Drug Rextoro

A Food and Drug Administration advisory cabinet on Thursday overwhelmingly deserted a new verbal testosterone-replacement drug called Rextoro, a day after a row voted to shorten a use of such products generally since of their cardiovascular risk.

Voting 18-3, a cabinet pronounced that a benefit-risk form of a drug, from privately-held Clarus Therapeutics Inc., wasn’t sufficient to approve it. Testosterone-replacement drugs are dictated for group who, for genetic or illness reasons, have low testosterone. But in…

About admin

Scroll To Top